相关实验视频
Updated: Jun 26, 2025

11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
10.4K
糖基化向:癌症免疫治疗中的范式转变
Xueting Ren1, Shuai Lin1, Feng Guan2
1Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
International journal of biological sciences
|May 10, 2024
概括
针对异常的癌细胞糖化化可以提高免疫治疗的有效性. 通过糖化策略来修改瘤微环境,可以提高抗瘤免疫力和治疗响应率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 免疫疗法,包括免疫检查点抑制剂,显示出希望,但面临着瘤免疫逃脱和低反应率的挑战.
- 异常的糖化是癌症的一个关键特征,影响瘤细胞的识别和抗瘤免疫反应.
- 瘤微环境 (TME) 在调节对抗癌症的免疫反应方面发挥着关键作用.
研究的目的:
- 审查异常糖基化如何影响TME内的抗瘤免疫力.
- 综合了针对癌症免疫治疗的向糖基化策略的最新进展.
- 提供一个理论框架,以了解糖化在免疫调节中的作用,用于临床应用.
主要方法:
- 对糖化,瘤微环境和免疫治疗研究的文献综述.
- 分析改变糖基化影响免疫细胞功能和瘤识别的机制.
- 对针对癌症糖化酶的治疗干预措施的当前研究的综合.
主要成果:
- 瘤细胞上的异常糖化模式可以导致免疫逃避.
- 针对性调节糖基化可以改变TME,促进抗瘤免疫活性.
- 基于糖化基的策略显示出改善患者对免疫疗法的反应的潜力.
结论:
- 糖化是癌症免疫逃脱和免疫疗法的有效性的一个关键因素.
- 向癌症特异性糖基化为新型免疫治疗方法提供了一个有希望的途径.
- 对糖化在免疫代谢中的作用的进一步研究可以促进临床转化.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cancer Vaccines
358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

